Annual SG&A:
$86.24M+$32.05M(+59.14%)Summary
- As of today, RNA annual SG&A is $86.24 million, with the most recent change of +$32.05 million (+59.14%) on December 31, 2024.
- During the last 3 years, RNA annual SG&A has risen by +$60.05 million (+229.22%).
- RNA annual SG&A is now at all-time high.
Performance
RNA SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$36.86M(-100.00%)Summary
- As of today, RNA quarterly SG&A is $0.00, with the most recent change of -$36.86 million (-100.00%) on September 30, 2025.
- Over the past year, RNA quarterly SG&A has dropped by -$23.27 million (-100.00%).
- RNA quarterly SG&A is now -100.00% below its all-time high of $36.86 million, reached on June 30, 2025.
Performance
RNA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$4.41B-$549.79M(-14.25%)Summary
- As of today, RNA TTM SG&A is -$4.41 billion, with the most recent change of -$549.79 million (-14.25%) on September 30, 2025.
- Over the past year, RNA TTM SG&A has dropped by -$4.48 billion (-6055.95%).
- RNA TTM SG&A is now -19772.23% below its all-time high of -$22.18 million.
Performance
RNA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
RNA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +59.1% | -100.0% | -6055.9% |
| 3Y3 Years | +229.2% | -100.0% | -10000.0% |
| 5Y5 Years | +1587.0% | -100.0% | -10000.0% |
RNA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +229.2% | -100.0% | at low | -351.8% | at low |
| 5Y | 5-Year | at high | +1587.0% | -100.0% | at low | -3059.3% | at low |
| All-Time | All-Time | at high | +3433.0% | -100.0% | at low | >-9999.0% | at low |
RNA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $98.80M(-19.1%) |
| Jun 2025 | - | $36.86M(+9.7%) | $122.08M(+15.2%) |
| Mar 2025 | - | $33.60M(+18.6%) | $105.94M(+22.8%) |
| Dec 2024 | $86.24M(+59.1%) | $28.34M(+21.8%) | $86.24M(+16.5%) |
| Sep 2024 | - | $23.27M(+12.3%) | $74.02M(+14.8%) |
| Jun 2024 | - | $20.73M(+49.2%) | $64.48M(+15.1%) |
| Mar 2024 | - | $13.90M(-13.8%) | $56.02M(+3.4%) |
| Dec 2023 | $54.19M(+43.6%) | $16.12M(+17.4%) | $54.19M(+11.8%) |
| Sep 2023 | - | $13.73M(+11.8%) | $48.45M(+8.1%) |
| Jun 2023 | - | $12.28M(+1.8%) | $44.82M(+8.7%) |
| Mar 2023 | - | $12.06M(+16.2%) | $41.23M(+9.3%) |
| Dec 2022 | $37.73M | $10.38M(+2.9%) | $37.73M(+8.5%) |
| Sep 2022 | - | $10.09M(+16.2%) | $34.78M(+11.1%) |
| Jun 2022 | - | $8.69M(+1.4%) | $31.30M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $8.57M(+15.3%) | $28.88M(+10.2%) |
| Dec 2021 | $26.20M(+94.6%) | $7.43M(+12.4%) | $26.20M(+11.1%) |
| Sep 2021 | - | $6.61M(+5.5%) | $23.58M(+13.8%) |
| Jun 2021 | - | $6.27M(+6.5%) | $20.73M(+19.2%) |
| Mar 2021 | - | $5.88M(+22.2%) | $17.38M(+29.1%) |
| Dec 2020 | $13.46M(+163.3%) | $4.82M(+28.2%) | $13.46M(+55.7%) |
| Sep 2020 | - | $3.76M(+28.4%) | $8.65M(+53.1%) |
| Jun 2020 | - | $2.92M(+48.9%) | $5.65M(+30.8%) |
| Mar 2020 | - | $1.96M(+159.4%) | $4.32M(+32.2%) |
| Dec 2019 | $5.11M(+109.4%) | - | - |
| Sep 2019 | - | $757.00K(-52.6%) | $3.27M(+30.2%) |
| Jun 2019 | - | $1.60M(+75.0%) | $2.51M(+175.0%) |
| Mar 2019 | - | $912.00K | $912.00K |
| Dec 2018 | $2.44M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual SG&A?
- What is the all-time high annual SG&A for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual SG&A year-on-year change?
- What is Avidity Biosciences, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly SG&A year-on-year change?
- What is Avidity Biosciences, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM SG&A year-on-year change?
What is Avidity Biosciences, Inc. annual SG&A?
The current annual SG&A of RNA is $86.24M
What is the all-time high annual SG&A for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual SG&A is $86.24M
What is Avidity Biosciences, Inc. annual SG&A year-on-year change?
Over the past year, RNA annual SG&A has changed by +$32.05M (+59.14%)
What is Avidity Biosciences, Inc. quarterly SG&A?
The current quarterly SG&A of RNA is $0.00
What is the all-time high quarterly SG&A for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly SG&A is $36.86M
What is Avidity Biosciences, Inc. quarterly SG&A year-on-year change?
Over the past year, RNA quarterly SG&A has changed by -$23.27M (-100.00%)
What is Avidity Biosciences, Inc. TTM SG&A?
The current TTM SG&A of RNA is -$4.41B
What is the all-time high TTM SG&A for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM SG&A is -$22.18M
What is Avidity Biosciences, Inc. TTM SG&A year-on-year change?
Over the past year, RNA TTM SG&A has changed by -$4.48B (-6055.95%)